LEADER 01125nam--2200385---4500 001 990000509070203316 005 20050606142424.0 010 $a0-19-437073-9 035 $a0050907 035 $aUSA010050907 035 $a(ALEPH)000050907USA01 035 $a0050907 100 $a20010614d19821983km-y0ENGy0103----ba 101 $aeng 102 $aGB 200 1 $aError analysis and interlanguage$fS.P. Corder 210 $aOxford$cOxford university$d1982 215 $a120 p.$d22 cm 410 $12001 606 0 $aLinguistica applicata$xSaggi 676 $a418 700 1$aCORDER,$bS. Pit$0456345 801 0$aIT$bsalbc$gISBD 912 $a990000509070203316 951 $aIV.2. 1057(II i D 273)$b98130 LM$cII i D 951 $aVII.3.D.288(II.i.D.273)$b98130 L.M.$cII.i 959 $aBK 969 $aUMA 979 $aPATTY$b90$c20010614$lUSA01$h1247 979 $c20020403$lUSA01$h1659 979 $aPATRY$b90$c20040406$lUSA01$h1635 979 $aCOPAT2$b90$c20050519$lUSA01$h1100 979 $aCOPAT7$b90$c20050606$lUSA01$h1424 996 $aError analysis and interlanguage$9887147 997 $aUNISA LEADER 00916cam a2200265 i 4500 001 991002687489707536 008 150226s2010 it b 000 0 ita d 020 $a9788816409514 035 $ab14216838-39ule_inst 040 $aDip. Stidi Giuridici$bita 082 04$a333.2 100 1 $aRicoveri, Giovanna$0229614 245 10$aBeni comuni vs merci /$cGiovanna Ricoveri 246 3 $aBeni comuni versus merci 260 $aMilano :$bJaca book,$c2010 300 $a114 p. ;$c23 cm 440 0$aDi fronte e attraverso ;$v951 440 0$aTerra terra 650 4$aRisorse comuni 907 $a.b14216838$b09-04-15$c26-02-15 912 $a991002687489707536 945 $aLE027 333.20 RIC01.01$g1$i2027000330881$lle027$nProf.ssa Tommasi$op$pE14.00$q-$rl$s- $t0$u3$v0$w3$x0$y.i15665756$z09-04-15 996 $aBeni comuni vs merci$9257366 997 $aUNISALENTO 998 $ale027$b26-02-15$cm$da $e-$fita$git $h0$i0 LEADER 04206oam 2201009 a 450 001 9910816151003321 005 20251116135721.0 010 $a9781118799529 010 $a1118799526 010 $a9781118799536 010 $a1118799534 035 $a(CKB)2670000000617960 035 $a(EBL)1985785 035 $a(SSID)ssj0001515602 035 $a(PQKBManifestationID)12550793 035 $a(PQKBTitleCode)TC0001515602 035 $a(PQKBWorkID)11482716 035 $a(PQKB)11758313 035 $a(DLC) 2015019440 035 $a(Au-PeEL)EBL4038783 035 $a(CaPaEBR)ebr11112583 035 $a(CaONFJC)MIL788215 035 $a(PPN)190377992 035 $a(OCoLC)909112553 035 $a(UkLoHST)3630 035 $a(MiAaPQ)EBC4038783 035 $a(UkLoHST)HST4519 035 $a(MiAaPQ)EBC1985785 035 $a(EXLCZ)992670000000617960 071 50$a4519$bHenry Stewart Talks 100 $a20171218d2017 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPulmonary drug delivery /$fAnthony J. Hickey 210 $aLondon $cHenry Stewart Talks$d2017 215 $a1 online resource (383 pages) 225 1 $aAdvances in asthma : new mechanisms, management strategies and treatments,$x2056-452X 225 1 $aDrug delivery,$x2056-452X 300 $aAnimated audio-visual presentation with synchronized narration. 300 $aTitle from title frames. 311 08$a9781118799505 311 08$a111879950X 311 08$a9781118799543 311 08$a1118799542 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aContents: Pulmonary drug delivery -- Therapeutic targets -- Drug categories -- Lung deposition and clearance -- Inhaled drug products -- Mechanism of droplet formation pMDIs -- In vitro tests -- In vivo considerations. 330 $aDrug therapy via inhalation route is at the cutting edge of modern drug delivery research. There has been significant progress on the understanding of drug therapy via inhalation products. However, there are still problems associated with their formulation design, including the interaction between the active pharmaceutical ingredient(s) (APIs), excipients and devices. This book seeks to cover some of the most pertinent issues and challenges of such formulation design associated with industrial production and desirable clinical outcome. The chapter topics have been selected with 410 0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pAdvances in asthma. 410 0$aHenry Stewart talks.$pBiomedical & life sciences collection.$pDrug delivery. 606 $aAerosol therapy 606 $aAntiasthmatic agents 606 $aDrug delivery systems 606 $aLungs$xDiseases$xTreatment 606 $aPharmaceutical technology 606 $aAdministration, Inhalation 606 $aAerosols$xtherapeutic use 606 $aAnti-Asthmatic Agents$xadministration & dosage 606 $aDrug Delivery Systems 606 $aLung Diseases$xdrug therapy 606 $aNebulizers and Vaporizers 606 $aPharmaceutical Preparations$xadministration & dosage 606 $aPulmonary Ventilation$xphysiology 615 0$aAerosol therapy. 615 0$aAntiasthmatic agents. 615 0$aDrug delivery systems. 615 0$aLungs$xDiseases$xTreatment. 615 0$aPharmaceutical technology. 615 2$aAdministration, Inhalation. 615 2$aAerosols$xtherapeutic use. 615 2$aAnti-Asthmatic Agents$xadministration & dosage. 615 2$aDrug Delivery Systems. 615 2$aLung Diseases$xdrug therapy. 615 2$aNebulizers and Vaporizers. 615 2$aPharmaceutical Preparations$xadministration & dosage. 615 2$aPulmonary Ventilation$xphysiology. 676 $a615.1 700 $aHickey$b Anthony J.$f1955-,$4spk$0554307 712 02$aHenry Stewart Talks (Firm) 801 0$bUkLoHST 801 1$bUkLoHST 906 $aBOOK 912 $a9910816151003321 996 $aPulmonary drug delivery$94136687 997 $aUNINA